# Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

> **NCT00918515** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 53 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD3043

## Key facts

- **NCT ID:** NCT00918515
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** —
- **Final completion:** 2009-08
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2009-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918515, "Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00918515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*